Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings
We advised Charles River on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
AN2 Therapeutics $69 million IPO
The shares are listed on the Nasdaq Global Select Market
Signify Health $250 million acquisition of Caravan Health
We are advising Signify Health on the transaction
Silver Spike Acquisition Corp. II combination with Eleusis
We are advising the SPAC on the transaction
Smith+Nephew acquisition of Engage Surgical
We are advising Smith+Nephew on the transaction
Convey Health Solutions acquisition of HealthSmart International
We are advising Convey Health Solutions on the transaction
Dynamics Special Purpose $601 million combination with Senti Biosciences
We are advising Dynamics, a SPAC, on the transaction
Novo Nordisk $3.3 billion acquisition of Dicerna Pharmaceuticals
We are advising Novo Nordisk on the transaction
BDT Capital Partners acquires a majority interest in MJH Life Sciences
We are advising BDT Capital Partners on the transaction
Triple-S Management $900 million acquisition by GuideWell
We are advising Triple-S on the transaction